An RSV Human Challenge Study of Palivizumab in Healthy Adult Participants

• Research type

  Research Study

• Full title

  A Double-Blind, Randomised, Placebo-Controlled Exploratory Study to Estimate the Prophylactic Efficacy of Palivizumab in Healthy Adult Participants Inoculated with Respiratory Syncytial Virus (RSV)

• IRAS ID

  1003216

• Contact name

  Sungeen Patel Hill

• Contact email

  s.hill@hvivo.com

• Eudract number

  2020-001044-26

• Research summary

  TBC

• REC name

  London - Hampstead Research Ethics Committee

• REC reference

  20/LO/0538

• Date of REC Opinion

  12 May 2020

• REC opinion

  Further Information Favourable Opinion